Literature DB >> 7644239

Systemic adenosine infusion: a new treatment modality to alleviate neuropathic pain.

Alf Sollevi1, Måns Belfrage, Thomas Lundeberg, Märta Segerdahl, Per Hansson.   

Abstract

Adenosine, an endogenous antinociceptive compound acting in the central nervous system, was infused intravenously (50-70 micrograms/kg/min) to 2 patients with peripheral neuropathic pain. In 1 subject, spontaneous pain was alleviated, and tactile allodynia was essentially relieved during 40 min of infusion. Allodynia to warmth and touch were abolished in the other subject. In addition, hyperalgesia to pinprick was markedly attenuated as was pressure-induced allodynia. The reported effects lasted for hours after termination of the infusion. Our preliminary encouraging data call for further controlled studies of the potentially relieving effect of adenosine in painful neuropathic conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7644239     DOI: 10.1016/0304-3959(94)00187-J

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  9 in total

1.  The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury.

Authors:  R Suzuki; L C Stanfa; E A Kowaluk; M Williams; M F Jarvis; A H Dickenson
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

2.  The efficacy of a novel adenosine agonist (WAG 994) in postoperative dental pain.

Authors:  R A Seymour; J E Hawkesford; C M Hill; J Frame; C Andrews
Journal:  Br J Clin Pharmacol       Date:  1999-06       Impact factor: 4.335

Review 3.  How do drugs relieve neurogenic pain?

Authors:  R Karlsten; T Gordh
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 3.923

Review 4.  Adenosine triphosphate: established and potential clinical applications.

Authors:  H J Agteresch; P C Dagnelie; J W van den Berg; J H Wilson
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

Review 5.  Clinical application of adenosine and ATP for pain control.

Authors:  Masakazu Hayashida; Ken-ichi Fukuda; Atsuo Fukunaga
Journal:  J Anesth       Date:  2005       Impact factor: 2.078

6.  Recombinant ecto-5'-nucleotidase (CD73) has long lasting antinociceptive effects that are dependent on adenosine A1 receptor activation.

Authors:  Nathaniel A Sowa; Meagen K Voss; Mark J Zylka
Journal:  Mol Pain       Date:  2010-04-14       Impact factor: 3.395

7.  Pain-relieving effects of intravenous ATP in chronic intractable orofacial pain: an open-label study.

Authors:  Ken-Ichi Fukuda; Masakazu Hayashida; Atsuo Fukunaga; Masataka Kasahara; Yoshihiko Koukita; Tatsuya Ichinohe; Yuzuru Kaneko
Journal:  J Anesth       Date:  2007-01-30       Impact factor: 2.078

Review 8.  Adenosine receptors: Emerging non-opioids targets for pain medications.

Authors:  Soo-Min Jung; Lee Peyton; Hesham Essa; Doo-Sup Choi
Journal:  Neurobiol Pain       Date:  2022-03-25

9.  Venlafaxine Attenuates Heat Hyperalgesia Independent of Adenosine or Opioid System in a Rat Model of Peripheral Neuropathy.

Authors:  Alireza Abed; Valiollah Hajhashemi; Hamid Reza Banafshe; Mohsen Minaiyan; Azam Mesdaghinia
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.